BioAtla BCAB
NASDAQ BCAB
$3.18 -0.05 (-1.55%)
At close: Aug 20, 2026 · 4:00 PM EDT

BioAtla (BCAB) Receivables (2025 - 2026)

BioAtla (BCAB) Receivables (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn 2.13 Bn
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn 6.57 Bn
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn 1.93 Bn
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn 160.00 Mn
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 1.06 Bn
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn 912.74 Mn
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn 215.33 Mn
8 Royalty Pharma 26.98 Bn 26.14 Bn - -
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn 1.09 Bn
10 BioAtla 5.28 Mn 5.28 Mn - 6.50 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 6.50 Mn
Dec 31, 2025 3.10 Mn